Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900029 · ClinicalTrials.gov registry record
Safety Follow-Up to HP 802-247-09-015
A clinical trial, sponsored by Healthpoint.
- Completed
- Registry status
- 206
- Enrollment target
NCT00900029: Completed study, sponsored by Healthpoint.
NCT00900029 is a clinical trial that has completed, run by Healthpoint. The registered enrollment target is 206 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00900029 has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
Study Summary
This is a 24-week observational follow safety study for Study 802-247-09-015.
Primary Outcome
At each visit the status of closed target ulcers was evaluated as remained closed or re-opened.
Interventions
- BIOLOGICAL No HP802 Treatment
- OTHER No HP802 Vehicle Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-01 |
What the finished NCT00900029 record still lists
NCT00900029 is an observational study that tracks outcomes without assigning an intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which No HP802 Treatment is the first listed.
NCT00900029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00900029 about?
NCT00900029 is a clinical study titled "Safety Follow-Up to HP 802-247-09-015". This is a 24-week observational follow safety study for Study 802-247-09-015.
What is the current status of trial NCT00900029?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2009-06. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00900029?
The interventions under investigation include: No HP802 Treatment (BIOLOGICAL), No HP802 Vehicle Treatment (OTHER).
Who is sponsoring clinical trial NCT00900029?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia